Weight loss guaranteed! But what impact on your diet? A review of GLP-1 and GIP/GLP-1 interventions

FHS
July 30, 2024
3:10 am

Researchers reviewed studies on dietary impacts of GLP-1 and GIP/GLP-1 receptor agonists in obesity and T2D patients, finding significant caloric reduction but limited evaluation of dietary composition.

The benefits of using a nimble platform from phase to phase – Pharmaceutical Technology

There are many advantages available in using the same digital platform for each phase of a clinical trial. Credit: fizkes via Shutterstock. By streamlining data

October 4, 2024

Testing begins for a new form of PrEP

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Jason Mast

June 5, 2024

Moderate or Severe Head Trauma Tied to Brain Cancer Risk in Young Veterans

Moderate/severe and penetrating traumatic brain injuries (TBIs) were linked with subsequent brain cancer, a retrospective study of U.S. veterans of the Iraq and Afghanistan wars

February 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.